On September 1, the U.S. Court of Appeals for the Federal Circuit affirmed a $112 million win for Knobbe Martens client CardiAQ in its trade secret misappropriation case against former…

Partner Ben Katzenellenbogen was quoted in “A Newcomer’s Guide To Litigating Patent Cases In California,” an article published in Law360.  Excerpt: The high court’s May decision discarded rules that let patent…

Associate Lesley Kim and Partner Robb Roby were quoted in “Life-Hacking Your Living Room,” an article published in The Ringer.  Excerpt: Deciding whether a dupe crosses a legal line is difficult….

Knobbe Martens is pleased to announce that partner Douglas G. Muehlhauser has been selected by The Recorder as one of just four intellectual property litigators to receive the “Giant Slayers”…

Partner Douglas G. Muehlhauser was quoted in “Sony’s Headphone Patent Rehearing Bid Nixed Under Nautilus,” an article published in Law360.  Excerpt: Without elaborating on its reasoning, the full Federal Circuit on Monday unanimously denied…

Partner Kerry Taylor was quoted in “Allergan IP Deal With Tribe Could Have Big Impact On PTAB,” an article published in Law360.  Excerpt: Allergan PLC’s attempt to use a Native American tribe’s…

Partner Brent Babcock was quoted in, “Life After 5: Issues Facing The PTAB,” an article published in Law360.  Excerpt: It’s been five years since America Invents Act reviews at the Patent Trial…

Partner Mike Fuller was quoted in, “A Native American Tribe, a Drugmaker and an Unusual Patent Plan,” an article published in Bloomberg Technology.  Excerpt: Allergan Plc has found an unusual way to…

Partner Mike Fuller was quoted in, “This Shield of Patents Protects the World’s Best-Selling Drug,” an article published in Bloomberg Businessweek.  Excerpt: The more than 100 patents AbbVie has secured over Humira’s…

Knobbe Martens has once again been recognized by Law360 as one of the most diverse law firms in the United States. The publication released its 2017 Diversity Snapshot this week,…